Amgen Inc (AMGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$326.01

Buy

$327.96

arrow-down$-0.73 (-0.22%)

Prices updated at 18 Dec 2025, 00:40 EST

Prices minimum 15 mins delay

Prices in USD

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

NASDAQ

-1.81%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	28,190m	33,424m
	19,739m	20,566m
	7,897m	7,258m
	28.01	21.71
	6,717m	4,090m
	14,801m	13,356m
Sales, General and administrative	6,179m	7,096m
Interest expenses	2,875m	3,155m
Provision for income taxes	1,138m	519m
Operating expenses	11,842m	13,308m
Income before taxes	7,855m	4,609m
Net income available to common shareholders	6,717m	4,090m
	12.56	7.62
Net interest income	-2,875m	-3,155m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	12.49	7.56
Free cash flow per share	17.4331	11.6298
Book value/share	14.2996	14.0168
Debt equity ratio	10.136393	9.622086

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	30,332m	29,030m
Current liabilities	18,392m	23,099m
Total capital	69,402m	62,426m
Total debt	64,613m	60,099m
Total equity	6,232m	5,877m
Total non current liabilities	-	-
Loans	63,170m	56,549m
Total assets	97,154m	91,839m
Total liabilities	-	-
Cash and cash equivalents	10,944m	11,973m
Common stock	535m	537m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	7,629m	10,944m
Cash dividends paid	-4,556m	-4,832m
	7,359m	10,394m
Investments (gains) losses	-26,204m	-1,046m
	10,944m	11,973m
Net income	-	-
	8,471m	11,490m
	-1,112m	-1,096m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.